124 related articles for article (PubMed ID: 121190)
1. [Exploration of new anti-cancer drugs(reviews) (author's transl)].
Morita N; Nagai T; Tomomatsu H; Yunoki K
Igaku Kenkyu; 1979 Sep; 49(3):288-309. PubMed ID: 121190
[No Abstract] [Full Text] [Related]
2. [Studies on antitumor effects of guanidino compounds and complexone derivatives (author's transl)].
Nagai T
Igaku Kenkyu; 1978 Jun; 48(5):333-467. PubMed ID: 102101
[No Abstract] [Full Text] [Related]
3. [New models of experimental chemotherapy of tumors].
Treshchalina EM; Andronova NV; Kobliakov VA; Raĭkhlin NT
Vopr Onkol; 2001; 47(6):701-5. PubMed ID: 11826492
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic activity of C-283 preparation (Ledakrin) in model experiments.
Radzikowski C
Mater Med Pol; 1976; 8(3):345-9. PubMed ID: 1034860
[No Abstract] [Full Text] [Related]
5. The primary cultures of animal ascites tumor cells growth in tubes in suspension as a model in the screening of antitumor agents.
Ivanitskaya LP; Makukho LV
Neoplasma; 1975; 22(1):105-7. PubMed ID: 1153034
[TBL] [Abstract][Full Text] [Related]
6. [Toxicity and antineoplastic activity of a new thio-TEPA analog].
Konovalova NP; D'iachkovskaia RF; Kiseleva EG
Vopr Onkol; 1973; 19(1):58-63. PubMed ID: 4349733
[No Abstract] [Full Text] [Related]
7. [Antineoplastic activity of preparations of the series of phenoxazine dyes].
D'iachkovskaia RF; Parkhomenko II; Vasil'eva LS; Surkova NI; Shuppe NG; Konovalova NP; Bogdanov GN; Emanuel' NM
Farmakol Toksikol; 1969; 32(1):84-7. PubMed ID: 5770324
[No Abstract] [Full Text] [Related]
8. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
Iaremenko KV; Eremeeva AA; Tereshin IM
Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
[No Abstract] [Full Text] [Related]
9. An approach to tumour biology in the light of prevention, cure and etiology.
Bose S; Chowdhury JR
Indian J Cancer; 1972 Jun; 9(2):138-41. PubMed ID: 4635904
[No Abstract] [Full Text] [Related]
10. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)].
Zhou JX; He GH; Tao LX; Xu B
Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026
[No Abstract] [Full Text] [Related]
11. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry. (II) (author's transl)].
Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M; Suzuki I; Odashima S
Eisei Shikenjo Hokoku; 1978; (96):91-4. PubMed ID: 750052
[No Abstract] [Full Text] [Related]
12. [The application of diffusion chamber culture of tumor cells in the screening of anti-tumor agents (author's transl)].
Wang JH; You YC; Mi JX; Liao Q; Yu YH
Yao Xue Xue Bao; 1980 Dec; 15(12):705-10. PubMed ID: 7257795
[No Abstract] [Full Text] [Related]
13. The specificity of inhibition of tumor cell viability by DNA.
Glick JL
Cancer Res; 1967 Dec; 27(12):2338-41. PubMed ID: 4866763
[No Abstract] [Full Text] [Related]
14. [Comparative evaluation of the action of oxythiamine and its derivatives on animals with Erhlich's ascitic cancer].
Zimatkina TI; Zimatkin SM; Oparin DA; Velichko MG; Ostrovskiĭ IuM
Eksp Onkol; 1986; 8(2):68-70. PubMed ID: 3698885
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
Mihich E; Nichol CA
Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
[No Abstract] [Full Text] [Related]
16. Studies on the effect of antifolics in mouse leukemia.
Motycka K
Natl Cancer Inst Monogr; 1971 Dec; 34():167-77. PubMed ID: 4110901
[No Abstract] [Full Text] [Related]
17. [The potential for enhancing the therapeutic efficacy of antitumor preparations].
Konovalova NP; Volkova LM; Klochko AV
Izv Akad Nauk SSSR Biol; 1989; (3):466-8. PubMed ID: 2760333
[TBL] [Abstract][Full Text] [Related]
18. [Cytotoxic changes in the nucleic acid content in a culture of tumor and normal cells as affected by a complex preparation from Bacillus mesentericus AB-56].
Khomiak OG; Volynets AK; Gushcha KP
Mikrobiol Zh (1978); 1981; 43(5):650-6. PubMed ID: 6171711
[No Abstract] [Full Text] [Related]
19. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
[No Abstract] [Full Text] [Related]
20. [Change in the cell cycle in a population of Ehrlich ascitic tumor cells as affected by an antiblastoma preparation].
Dubinskaia SN; Zelenkova NP; Zaikonnikova IV; Studenkotsova IA
Tsitol Genet; 1983; 17(2):54-8. PubMed ID: 6679411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
